Literature DB >> 22934580

Clinical and radiographic features of moyamoya disease in patients with both cerebral ischaemia and haemorrhage.

Tomohito Hishikawa1, Koji Tokunaga, Kenji Sugiu, Isao Date.   

Abstract

OBJECTIVES: Patients with moyamoya disease (MMD) very rarely develop both cerebral ischaemia and haemorrhage. The aim of this study was to clarify the clinical and radiographic features of MMD in patients who presented with both ischaemia and haemorrhage, compared with MMD patients who presented with one or the other.
MATERIALS AND METHODS: The records of 92 consecutive patients with MMD were reviewed. These patients were divided into three groups, according to the type of presentation: ischaemic presentation (Group I); haemorrhagic presentation (Group H); and haemorrhagic-ischaemic presentation (Group H-I). The patient characteristics, areas of infarction, and angiographic findings were evaluated.
RESULTS: Seventy-six (82%) of the 92 patients were categorised as Group I, 7 (8%) as Group H, and 9 (10%) as Group H-I. Median follow-up periods for Group H-I was 55 months (IQR, 36-116 months). There were eight females in Group H-I, in which the median age was 30 years. Of the nine cases in Group H-I, six presented with cerebral haemorrhage as the precedent event and three had complications during the acute phase. In Group H-I, the prevalence of posterior cerebral artery (PCA) lesions was high (42%) and infarctions were most frequently found in PCA-related areas.
CONCLUSIONS: The presence of steno-occlusive PCA lesions may be of pathogenic importance in MMD patients who develop both cerebral ischaemia and haemorrhage. The prevalence of this type of stroke in MMD patients is higher than expected, and further investigation in clinical settings is thus warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22934580     DOI: 10.3109/02688697.2012.717983

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  9 in total

1.  [Characteristics of collateral circulation in adult moyamoya disease based on modified Suzuki staging].

Authors:  Qing-Shun Zhao; Gang Wang; Hao-Jiang Xiao; Wen-Feng Feng; Guo-Zhong Zhang; Ming-Zhou Li; Yong-Hong Liao; Yun-Yu Wen; Song-Tao Qi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Cerebrovascular collaterals correlate with disease severity in adult North American patients with Moyamoya disease.

Authors:  M K Strother; M D Anderson; R J Singer; L Du; R D Moore; Y Shyr; T R Ladner; D Arteaga; M A Day; P F Clemmons; M J Donahue
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-20       Impact factor: 3.825

3.  Clinical and angiographic features and stroke types in adult moyamoya disease.

Authors:  D-K Jang; K-S Lee; H K Rha; P-W Huh; J-H Yang; I S Park; J-G Ahn; J H Sung; Y-M Han
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

4.  Editorial for "Pre-Surgical Magnetic Resonance Imaging Indicators of Revascularization Response in Adults With Moyamoya Vasculopathy".

Authors:  Yibin Xie
Journal:  J Magn Reson Imaging       Date:  2022-03-17       Impact factor: 5.119

Review 5.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

6.  Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.

Authors:  Won-Hyung Kim; Sang-Dae Kim; Myung-Hyun Nam; Jin-Man Jung; Sung-Won Jin; Sung-Kon Ha; Dong-Jun Lim; Hae-Bin Lee
Journal:  Childs Nerv Syst       Date:  2018-10-03       Impact factor: 1.475

7.  Long-term mortality in patients with moyamoya angiopathy according to stroke presentation type in South Korea.

Authors:  Sang-Hyuk Im; Dong-Kyu Jang; Hoon Kim; Sang-Kyu Park; Kyung-Do Han
Journal:  Acta Neurochir (Wien)       Date:  2021-08-24       Impact factor: 2.216

Review 8.  Moyamoya Biomarkers.

Authors:  Edward R Smith
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

9.  CRISPR Detection and Research on Screening Mutant Gene TTN of Moyamoya Disease Family Based on Whole Exome Sequencing.

Authors:  Yilei Xiao; Weidong Liu; Jiheng Hao; Qunlong Jiang; Xingbang Wang; Donghu Yu; Liyong Zhang; Zhaogang Dong; Jiyue Wang
Journal:  Front Mol Biosci       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.